整合机器学习生存框架,用于在一个大型多中心的NSCLC队列共识建模,NSCLC耐药的aumolertinib
Xiao Wu1, Yang Lu2, Yongping Li3
1The First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Scientific reports
|October 29, 2025
概括
一个新的预后签名 (ARRPS) 预测了非小细胞肺癌 (NSCLC) 患者的预后结果,这些患者接受了auomolertinib (AUM) 治疗. ARRPS可以指导个性化治疗来克服药物耐药性.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 具有EGFR突变的高级非小细胞肺癌 (NSCLC) 经常对第三代氨酸激酶抑制剂 (TKI) 响应,如阿莫尔蒂尼布 (AUM).
- 获得对AUM的耐药性限制了它在NSCLC患者的长期临床有效性.
研究的目的:
- 识别与NSCLC中AUM耐药性相关的基因.
- 开发一种基于机器学习的AUM抗性的预后签名.
- 探索潜在的组合疗法,以克服AUM耐药性.
主要方法:
- 建立了AUM抗性NSCLC细胞系的体外模型.
- 进行RNA测序以识别差异表达的基因.
- 利用机器学习来构建AUM阻力相关预测签名 (ARRPS).
主要成果:
- 确定了与AUM耐药性相关的关键差异表达基因.
- 开发了ARRPS,证明了其在预测患者预后风险方面的有效性.
- 发现将AUM与CD-437或TPCA-1结合起来,可以在ARRPS得分高的患者中克服耐药性.
结论:
- 对于接受AUM治疗的NSCLC患者来说,ARRPS是一种有价值的预后工具.
- ARRPS可以指导个性化治疗策略,以改善临床结果.
- 针对性组合疗法在特定患者亚组中有望克服AUM耐药性.
更多相关视频
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
482
08:52Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Published on: November 22, 2021
4.5K
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Assumptions of Survival Analysis
391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
